Aims In this study, we wished to determine whether angiopoietin-1 (Ang1) modified the permeability coefficients of non-inflamed, intact continuous, and fenestrated microvessels in vivo and to elucidate the underlying cellular mechanisms. Methods and results Permeability coefficients were measured using the Landis-Michel technique (in frog and rat mesenteric microvessels) and an oncopressive permeability technique (in glomeruli). Ang1 decreased water permeability (L P : hydraulic conductivity) in continuous and fenestrated microvessels and increased the retention of albumin (s: reflection coefficient) in continuous microvessels. Endothelial glycocalyx is common to these anatomically distinct microvascular beds, and contributes to the magnitude of both L P and s. Ang1 treatment increased the depth of endothelial glycocalyx in intact microvessels and increased the content of glycosaminoglycan of cultured microvascular endothelial cell supernatant. Ang1 also prevented the pronase-induced increase in L P (attributable to selective removal of endothelial glycocalyx by pronase) by restoration of glycocalyx at the endothelial cell surface. The reduction in permeability was inhibited by a cell transport inhibitor, Brefeldin. Conclusion Ang1 modifies basal microvessel permeability coefficients, in keeping with previous reports demonstrating reduced solute flux in inflamed vessels. Anatomical, biochemical, and physiological evidence indicates that modification of endothelial glycocalyx is a novel mechanism of action of Ang1 that contributes to these effects.
Introduction
Ang1 is a 70-kDa glycoprotein that shares homology with a number of other angiopoietins and angiopoietin-like molecules. 1 Their expression and activity have been demonstrated across a range of vertebrate families encompassing mammals 2,3 and amphibians. 4 Ang1 is a ligand for the tyrosine kinase receptor Tie2, expressed by endothelial cells throughout the vasculature, 1 and a small number of other cell types. 5 Ang1 is constitutively expressed and its receptor, Tie2, is constitutively phosphorylated in many adult tissues. 3 Endothelial cell responses to Ang1 in vitro include chemotaxis, prevention of apoptosis, sprouting, and tube formation. 1 Activities in vivo include reduction of leukocyte adhesion and other markers of inflammation, 6 and tissuespecific and time-specific alterations in angiogenesis. 7, 8 The primary function of the microvasculature is to regulate exchange of substances between plasma and abluminal compartments (e.g. interstitium, or urinary space in the case of glomeruli). The mass of solute and solvent crossing microvascular walls is determined by (i) the forces acting across microvessel walls that drive solute/solvent flux (net hydrostatic and oncotic pressure gradients, concentration gradients), (ii) haemodynamic forces (plasma flow rate, area available for exchange), and (iii) the permeability of microvessel walls.
Microvascular permeability [point (iii)] is described by three permeability coefficients: hydraulic conductivity (L P : the ease with which water crosses microvessel walls), reflection coefficient (s: the fraction of a solute that cannot be dragged across microvessel walls with the convective flux of solvent), and the diffusive solute permeability coefficient (P S : the degree to which microvessel walls hinder the diffusive movement of solute from lumen to abluminal compartment).
All previous studies that have attempted to investigate the effect of Ang1 on microvascular permeability in intact vessels have measured solute (or solvent) flux (determined by all three factors listed above), rather than measuring microvascular permeability (i.e. permeability coefficients) per se. The Miles Assay, 9 leak of fluorescent microspheres 10 and paw oedema 11 are all measures of the composite parameters of solute/solvent flux, rather than specific measures of the contribution of microvessel permeability coefficients to solute flux. Because Ang1 affects arteriolar resistance, 12 changes in hydrostatic pressure gradients, area available for exchange, plasma flow rate, and consequently concentration gradients are all likely to occur in response to Ang1. 13 These studies are limited in their ability to reveal the mechanisms by which Ang1 alters total solute flux in intact vessels in vivo, particularly under the baseline conditions under which the Ang1-Tie2 axis is active. 3 Ang1 would be predicted to alter solute flux by modulating the contribution of the endothelium to microvascular permeability, given the effects of this ligand on endothelial cell biology, and techniques that can discriminate changes in permeability coefficients from changes in haemodynamic forces and driving forces are necessary to demonstrate the contribution of altered permeability coefficients.
Evidence that Ang1 modifies permeability coefficients has been provided by in vitro studies, in which application of Ang1 to endothelial cell monolayers reduces both water and albumin flux, 14, 15 predominantly via alteration of the activity and expression of molecules involved in the integrity of inter-endothelial cell junctions, such as VE-cadherin, PECAM-1, and b-catenin. 14 It is critical to note, however, that the permeability coefficients of endothelial cell monolayers are both quantitatively and qualitatively different from those of intact microvessels in vivo: indeed, the permeability coefficients of endothelial cell monolayers are comparable to those of inflamed microvessels. 16 Ang1 has a multiplicity of anti-inflammatory actions, and all of the aforementioned studies of solute-solvent flux in vivo have examined the effects of Ang1 following an inflammatory stimulus. Ang1, however, is typically expressed under baseline (i.e. non-inflamed) conditions, and the effects of Ang1 on microvascular permeability and/or solute-solvent flux have not been examined under these baseline, non-inflamed conditions.
We therefore sought to examine whether Ang1 modifies microvascular permeability coefficients under conditions in which all other determinants of transvascular solute and solvent movement are known and controlled, and to determine these influences in the resting state, i.e. without prior induction of inflammation.
We also sought to compare the effects of Ang1 on the hydraulic conductivity of microvessels with continuous and fenestrated endothelia. Paracellular routes (i.e. through the inter-endothelial cleft) dominate fluid flux in continuous capillaries, 17 but transcellular routes (i.e. through the fenestrations) dominate fluid flux in fenestrated capillaries. 18 If Ang1 modifies permeability coefficients in intact microvessels via modification of inter-endothelial cleft molecules, then changes in continuous microvessel water permeability (L P ), but not fenestrated microvessel L P , would be expected in response to Ang1.
Methods

Animal preparation
Experiments on adult frogs (Rana temporaria) and rats (Wistar) were performed in accordance with both the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health and UK Home Office legislation. Mesenteric permeability experiments were performed as described by Bates and coworkers, 19 and glomerular permeability experiments as reported by Salmon et al. 20 (see Supplementary material online).
Systemic microvessel permeability coefficient measurement
In view of the difficulties in separating permeability coefficients using more widely used methodologies, we used the Landis-Michel micro-occlusion technique, as we have previously described in intact microvessels in vivo 19 (see Supplementary material online for details). This technique allows the precise measurement of permeability characteristics, as the intravascular forces that determine transvascular fluid and solute flux (hydrostatic and oncotic pressures) are controlled. Individual microvessels (16-37 mm; capillaries and post-capillary venules) of known surface area in the mesentery were cannulated with a bevelled micropipette, while the mesentery was superfused with Ringer's solution. The vessels were then perfused with bovine serum albumin (BSA) at a known concentration, and erythrocytes (as flow markers), at a defined pressure. To measure L P and s, vessels were occluded with a fine glass rod. Fluid filtration rate per unit area was calculated from the rate of erythrocyte movement and the cross-sectional area of the vessel. L P (Â10 27 cm s 21 cm H 2 O 21 ) was calculated from the slope of the relationship between filtration rate and applied pressure, and s from the abscissal intercept.
Permeability coefficients were measured before and after microvessel perfusion with recombinant human Ang1 (R&D Systems; 200 ng mL 21 ) or vehicle (1Â phosphate-buffered saline). In separate experiments on frog microvessels, the ability of Ang1 to inhibit the pronase-induced increase in L P that has previously been reported in the same system 21 was assessed by measuring L P during preperfusion of the microvessel with either Ang1 or vehicle solution for 30 min, followed by L P measurement after brief and transient (,90 s) microvessel perfusion with 0.1 mg mL 21 pronase, following which the initial perfusate (Ang1 or BSA) was restored (please see Supplementary material online for details). L P was also measured in vessels that were only perfused with Ang1 following pronase exposure. To examine whether Ang1 inhibits the translocation of pre-formed glycocalyx constituents from intracellular stores, frog microvessels were co-perfused with Ang1 (200 ng mL 21 ) and the Golgi vesicle translocation inhibitor 100 mm Brefeldin-A. 22 
Electron microscopy
Frog microvessels were perfused initially with BSA-Ringer containing Ang1 or vehicle, with or without subsequent pronase exposure, as for permeability studies. Thereafter, perfusion with albumin-free Ringer solution for 1 min, then Alcian Blue solution for 5 min, was instituted. Vessels were then fixed by flooding the mesentery with 4% ice-cold gluteraldehyde in cacodylate buffer. After fixation, Ang1 alters glycocalyx and permeability coefficients the position of the microvessel in the mesentery was drawn; the mesentery was cut away from the animal, stored in cacodylatebuffered 4% gluteraldehyde at 48C overnight, post-fixed in 1% osmium tetroxide, and embedded in araldite blocks using standard techniques. The perfused microvessel was identified in the block, and transverse ultrathin (100 nm) sections were prepared. The sections were stained with lead citrate and uranyl acetate before being viewed in a Phillips 100CS electron microscope. Images were prepared from between two and four vessels per treatment group (mean: 3.25 vessels).
Electron microscopy (EM) images of microvessels were analysed with Adobe Photoshop (R). A calibrated electronic grid was applied to EM images and (i) glycocalyx depth (luminal edge of plasmalemma to luminal edge of glycocalyx); (ii) glycocalyx separation from the plasmalemma (luminal edge of plasmalemma to the nearest detectable glycocalyx); and (iii) inter-endothelial cleft width (wide cleft regions only) were measured at regular 50 nm intervals. In addition, the number of tight junctions (electron dense, narrow, regions of inter-endothelial clefts) were recorded for each treatment group, and divided into the total cleft length for each treatment group, to reveal the mean cleft length per tight junction.
Glomerular permeability coefficient measurement
Glomeruli were isolated from rat kidneys using a standard sieving technique, 20 and treated with Ang1 or vehicle for 60 min in a blinded fashion. Individual glomeruli were loaded onto the tip of an aspiration micropipette within a flow-controlled glass observation chamber, and glomerular profile recorded during exchange of surrounding solution from 10 to 80 mg mL 21 BSA. The consequent rate of glomerular volume reduction (which represents the rate of flux of fluid from glomerular capillary lumina across the glomerular filtration barrier: J V ) was analysed off-line. Glomerular hydraulic conductivity-surface area product (L P A) was calculated from the quotient of rate of volume change and applied oncotic pressure:
Endothelial cell glycosaminoglycan assay in vitro
Adult dermal human microvascular endothelial cells (Cambrex) were grown to 60-70% confluency, serum-starved for 24 h and then exposed to Ang1 or vehicle for 48 h. Supernatant was then aspirated, centrifuged, incubated with papain (to eliminate interference from proteins and glycoproteins 23, 24 ) and added to an Alcian Blue solution. The linear relation between mass of glycosaminoglycan and the degree of reduction in 488 nm light absorption by Alcian Blue solution 25 was used to quantify supernatant glycosaminoglycan content.
Statistics
Mesenteric microvessel L P values are not normally distributed: 26 results are reported as median + semi-interquartile range, and analysed with non-parametric statistics. All other results are reported as mean + SEM, and compared with parametric statistics. For permeability coefficient experiments, numerical results and associated statistical evaluations are given in Table 1 .
Results
Angiopoietin-1 reduces L P of vessels with continuous endothelium
While L P was unaltered by BSA perfusion, luminal perfusion with 200 ng mL 21 Ang1 caused a significant reduction in L P of frog microvessels. The reduction in L P was complete after 20 min, and no further reductions in L P were observed during the following 40 min of perfusion with Ang1 ( Figure 1A and B) . Identical effects were observed in a mammalian system (rat mesenteric microvessels: Figure 1C and D). There was no relation between the magnitude of fall in L P and baseline L P ( Figure 1E ). The effect of Ang1 on L P was reversible, in that L P returned to baseline levels 30 min after removal of Ang1 from the perfusate (Figure 1 , Supplementary material online).
Angiopoietin-1 increases s of vessels with continuous endothelium
Measurement of filtration rate under increasing pressure in the vessel ( Figure 2 ) was performed in 10 vessels. The slope of the relation between J v and P c (i.e. the hydraulic conductivity, L P ) was (again) significantly reduced by Ang1. The abscissal intercept of the relation between J v and P c [i.e. the mean effective oncotic pressure (sDp) difference across the vessel wall] was significantly elevated by Ang1: this corresponds to an increase in albumin reflection coefficient (s alb , i.e. a decrease in macromolecular permeability) from 0.78 + 0.03 to 0.91 + 0.03 (n ¼ 10 pairs; P , 0.001, paired t-test). This effect was observed in all the 10 vessels studied ( Figure 2) , and was observed even in vessels with the highest baseline values of sDp. As for L P , s returned to baseline values 30 min after removal of Ang1 from the perfusate (Figure 1 , Supplementary material online).
Angiopoietin-1 reduces L P A of vessels with fenestrated endothelium
Treatment with 200 ng mL 21 Ang1 reduced the hydraulic conductivity of fenestrated rat glomerular capillaries to 76% of control, assuming no change in glomerular vascular area during the measurement (Figure 3) . Ang1 was therefore able to reduce vascular permeability to water both in vessels with continuous and fenestrated endothelium. We therefore investigated the possibility that Ang1 modified a structure that is present in both continuous and fenestrated microvessels, and contributes to hydraulic resistance and macromolecular sieving properties in both the vessel types: the endothelial glycocalyx.
Angiopoietin-1 prevents the pronase-induced increase in L P in vivo
Using the Landis-Michel technique, Adamson showed that brief perfusion of frog mesenteric microvessels with pronase caused both selective removal of the endothelial glycocalyx (but leaves the underlying endothelial cells intact) and a 2.5-fold increase in L P . 21 We have used the same protocol in the same animal species to examine whether Ang1 modifies permeability coefficients by modifying endothelial glycocalyx.
Transient perfusion of vessels with pronase caused a 2.6 + 0.4-fold increase in L P over baseline (n ¼ 9). This pronase-induced increase in L P was attenuated to 1.2 + 0.3-fold in vessels pre-perfused with Ang1 for 30 min (n ¼ 6; P , 0.05, unpaired t-test; Figure 3C ). Perfusing vessels with Ang1 for 30-45 min after exposure to pronase also attenuated the pronase-induced L P increase, when compared with pronase treatment alone (pronase alone: 3.6 + 1.1-fold increase in L P over baseline (n ¼ 4); pronase followed by Ang1: 1.5 + 0.2-fold increase in L P over baseline (n ¼ 5; P , 0.05, Mann-Whitney U test; Figure 3D ).
Angiopoietin-1 modifies endothelial glycocalyx
To visualize whether Ang1 modified the glycocalyx, the glycocalyx was stained in perfused vessels with Alcian Blue, and processed and examined by electron microscopy (Figure 4) . Perfusion with Alcian Blue resulted in the staining of a 50-100 nm thick glycocalyx attached to, but above the plasmalemma ( Figure 4A) . Perfusion with Ang1 resulted in a thicker layer, which upon higher power examination could be seen to be a diffuse glycocalyx ( Figure 4B ) still attached to the plasmalemma. Treatment with pronase resulted in a darker stained glycocalyx ( Figure 4C) , which was clearly separated from the plasmalemma (arrows, Figure 4C ). Subsequent treatment with Ang1 restored direct contact between glycocalyx and plasmalemma ( Figure 4D) .
To quantify changes, the depth of endothelial glycocalyx in microvessels perfused with BSA alone, as determined with Alcian Blue staining and electron microscopic analysis, was measured. In control, the glycocalyx was 44.5 + 3.6 nm (n ¼ 96 measurements; n ¼ 6 images, Figure 5A ); glycocalyx depth in vessels perfused with Ang1 for 30 min was 87.1 + 3.2 nm (n ¼ 171 measurements; n ¼ 6 images; P , 0.05, unpaired t-test; Figure 5A ). Pronase exposure reduced the depth of glycocalyx to 31.7 + 1.5 nm [n ¼ 104 measurements, n ¼ 20 images; control: 44.5 + 3.6 nm; P , 0.05, one-way analysis of variance (ANOVA), Bonferroni]. In addition, pronase treatment elicited a significant separation of the glycocalyx from the underlying endothelial cell plasma membrane that was not evident under baseline conditions (6.9 + 0.4 nm; Figure 5B ; n ¼ 104 measurements, n ¼ 20 images). Ang1 treatment replenished this pronase-induced gap, immediately adjacent to the plasmalemma, with glycocalyx (separation 2.5 + 0.4 nm; n ¼ 66 measurements, n ¼ 14 images; P , 0.05 vs. pronase alone, one-way ANOVA, Bonferroni, Figure 5B ). However, total depth of glycocalyx was not preserved by Ang1 pretreatment (21.4 + 0.9 nm (n ¼ 66 measurements, n ¼ 14 images; not significantly different from pronase alone: P . 0.05, one-way ANOVA, Bonferroni). There was no difference in inter-endothelial cleft width between control [21.1 + 1.6 nm (n ¼ 6)] and Ang1 [20.6 + 1.8 nm (n ¼ 9)]-treated vessels (P . 0.8, unpaired t-test, Figure 5C ). In addition, cleft lengths (control: 306 nm; Ang1: 299 nm) were similar in control and Ang1-treated vessels and the frequency of tight junctions within inter-endothelial clefts (approximately one per cleft for each group) was also the same resulting in no difference between tight junction interval along the cleft ( Figure 5D ). There were also no 
Angiopoietin-1 modifies endothelial cell glycosaminoglycan turnover, inhibition of which blocks the Ang1 reduction in L P
To determine whether Ang1 could affect the rate of endothelial glycocalyx turnover, endothelial cells in culture were treated with Ang1 in vitro. This increased the mass of glycosaminoglycan constituents in the supernatant of endothelial cells (e.g. heparan sulphate) from 6.2 + 0.8 mg to 12.5 + 1.1 mg (P , 0.05, unpaired t-test; Figure 5E ). Glycocalyx is inserted onto the cell surface by vesicle fusion regulated by Golgi-mediated translocation. To determine whether this was required for the Ang1 effect in vivo, vessels were perfused with the Golgi vesicle translocation inhibitor brefeldin-A (100 mM) before treatment with Ang1. The reduction in baseline L P observed in response to Ang1 (Figure 1) was blocked by co-perfusing vessels with Ang1 (200 ng mL 21 ) and brefeldin A [Ang1 alone significantly lower than both control (P , 0.05) and Ang1þbrefeldin-A (P , 0.05); brefeldin-A not significantly different from control (P . 0.05; all one-way ANOVA, Figure 5F) ].
Discussion
We show here that perfusion of microvessels with continuous endothelium with Ang1 in vivo lowers baseline L P and increases reflection of albumin by the microvessel wall. This was demonstrated in non-inflamed vessels, in which L P and s are the same as values previously reported for noninflamed vessels in frogs 27 and rats. 28 The majority of reports demonstrating reduced transvascular solute movement following Ang1 treatment in vivo, or in intact organ preparations ex vivo, have either examined the effect of Ang1 following application of a stimulus (e.g. mustard oil 29 or bradykinin 10 ) or in animal models of disease (e.g. diabetic retinopathy 6 ). Reduced solute movement may be related to: a change in the permeability coefficients of vessel walls (such as L P and s); the extent of microvascular network perfusion; 30 the net driving forces for solute movement (e.g. reduced hydrostatic pressure resulting from vasoconstriction); a combination of these factors; or to a number of other factors. 13 The aforementioned studies did not discriminate between these factors. The results presented in this study are consistent with these reports, but show that one physiological mechanism for those observations is a direct effect of Ang1 on the permeability coefficients of microvascular walls.
We also show that Ang1 reduced the hydraulic conductivity-surface area product of the fenestrated glomerular capillary network, in agreement with reports of increased transendothelial electrical resistance (a marker of water and small solute permeability) across glomerular endothelial cell monolayers following Ang1 treatment. 15 These observations together highlight three actions of Ang1 on microvascular permeability coefficients: reduced L P of continuous microvessels; increased albumin reflection by continuous microvessels; and reduced L P A of fenestrated microvessels. The pathways that regulate these permeability coefficients have distinct components, and this diversity can provide insight into the cellular mechanisms underlying the Ang1 effect. L P values were restored towards baseline levels in pronase-exposed vessels subsequently perfused with 200 ng mL 21 rhAng1 (L P 1.5 + 0.2-fold higher than baseline (n ¼ 5; *P , 0.05 vs. pronase alone-treated vessels, Mann-Whitney U test).
The frequency of breaks in the tight junction strands in inter-endothelial clefts are a critical determinant of the L P of continuous microvessels. Substances that increase the number of tight junction strands present in inter-endothelial clefts (e.g. cAMP analogues) reduce baseline L P . 31 Ang1 modifies a number of inter-endothelial cleft molecules, e.g. occludin, PECAM-1, b-catenin, and VE-cadherin. 14, 32 These tight-junction strand breaks, however, are not significant regulators of the reflection coefficient of the vessel wall, 31 and changes in inter-endothelial clefts are therefore unlikely to explain the increase in s observed following application of Ang1. The cellular structure that correlates to the 'large pore' that governs the magnitude of s remains controversial: both trans-endothelial (vesiculo-vacuolar organelles, caveolae), and inter-endothelial pathways have been postulated. 17 Furthermore, reduced L P A in response to Ang1 in the fenestrated glomerular capillary network is unlikely to represent alterations in hydraulic interendothelial pathways. The vast majority of fluid flux across the glomerular endothelial cell layer is via fenestrae, rather than inter-endothelial clefts, 33 such that it seems highly unlikely that Ang1 reduces glomerular L P A by altering the clefts between glomerular endothelial cells.
It is conceivable that the plethora of observed actions of Ang1 on permeability coefficients are mediated by modification of a variety of different ultrastructural features of different microvascular beds that result in parallel changes in permeability coefficients. An alternative explanation is that Ang1 modifies a structure that is common to both continuous and fenestrated capillaries, and that contributes to both hydraulic conductivity and molecular sieving of microvessel walls. The endothelial glycocalyx appears to be a good candidate for this. The fibre-matrix junction break model, originally outlined by Curry and Michel in 1980, 34 proposes that the size, orientation and spacing of the fibres that form the endothelial glycocalyx layer on the luminal aspect of endothelial cells contribute to the resistance to water flow and molecular selectivity of the vessel wall. Endothelial glycocalyx lies across the surface of both inter-endothelial clefts in vessels with continuous endothelium 21 and across fenestrae in glomerular capillaries, 35 and endothelial glycocalyx has been shown to contribute to hydraulic resistance and molecular sieving in vessels with continuous endothelia 21, 36 and vessels with fenestrated endothelia. 37, 38 Modification of a number of features of glycocalyx by Ang1, such as depth and/or density, would be Figure 4 Angiopoietin-1 modifies endothelial glycocalyx in vivo. Electron micrographs of frog mesenteric microvessels following perfusion with (A) bovine serum albumin (BSA) alone, (B) Ang1, (C ) pronase, and (D) Ang1 before and after pronase. Following perfusion with experimental agents, microvessels were treated with Alcian Blue (to stain endothelial glycocalyx), fixed with glutaraldehyde, and prepared for electron microscopy. Endothelial glycocalyx was significantly deeper following Ang1 treatment (B). Glycocalyx was shallower and more electron dense after exposure to pronase, and was separated from the plasmalemma (double arrow head) (C). Near-continuity between glycocalyx and plasmalemma, but not glycocalyx depth, was restored by Ang1 treatment of pronase-exposed vessels (D). ESL, endothelial surface layer; L, lumen; G, glycocalyx; P, plasmalemma; EC, endothelial cell; V, vesicle; I, interstitium. expected to increase the hydraulic resistance (i.e. decrease L P or L P A) and to increase reflection of large solutes (i.e. increase s). 17 Ang1-induced changes in microvascular glycocalyx depth, and endothelial cell supernatant glycosaminoglycan content, support the contention that Ang1 modifies endothelial glycocalyx.
We have shown an increase in the depth of glycocalyx lining microvascular endothelial cells following perfusion with Ang1 for 30 min in vivo. The ultrastructural changes described here induced by Ang1 would be predicted to alter microvascular permeability characteristics (given the contribution that endothelial glycocalyx makes to the magnitude of permeability coefficients 21, 36, 37 ), but these observations do not by themselves demonstrate that the Ang1-induced change in permeability coefficients is mediated by an alteration in endothelial glycocalyx. However, taken together with the loss of the Ang1-induced reduction in L P by inhibition of the Golgi vesicle translocation system upon which translocation of glycosaminoglycans to the cell surface depends; 22, 39 both abrogation and accelerated recovery from the rise in L P that accompanies removal of the endothelial glycocalyx in vivo and that the prevention of pronase-induced increased L P was accompanied by restoration of near-continuity between the glycocalyx and the endothelial plasmalemma when the microvessels were pre-treated with Ang1, these findings strongly implicate the glycocalyx as being a key mechanism through which Ang1 exerts its permeability effects. Extracellular matrix modulates the activity and availability of endothelial cell survival factor pathways: 40 our observations indicate that this interaction is reciprocal, and that endothelial cell survival factors can also modulate extracellular matrix components, such as those in the endothelial glycocalyx. These observations do not preclude the possibility that Ang1 is also affecting other aspects of endothelial cell biology such as the density and activity of inter-endothelial Figure 5 Angiopoietin-1 modifies endothelial glycocalyx, but not inter-endothelial cleft ultrastructure. Inter-endothelial cleft and glycocalyx parameters were measured at regular 50 nm intervals in electron micrographs prepared from vessels perfused with control solution, angiopoietin-1, pronase, or pronase exposure in Ang1-perfused vessels. (A) Ang1 increased, and pronase decreased, glycocalyx depth. Ang1 perfusion did not alter glycocalyx depth in pronase-exposed vessels. (B) Pronase exposure caused separation of the glycocalyx from the plasmalemma; Ang1 reversed this effect (*P , 0.05, one-way analysis of variance). (C and D) There were no differences in the wide (C) or narrow (D) regions of inter-endothelial clefts between any experimental group. (E) Supernatant from human microvascular endothelial cells, cultured in the presence of 200 ng mL 21 Ang1 or vehicle for 48 h, was added to Alcian Blue solution. Ang1 treatment increased heparin sulphate equivalent (*P , 0.05, unpaired t-test). (F) The reduction in L P induced by Ang1 was abolished in the presence of the Golgi translocation inhibitor Brefeldin-A. junction molecules, thereby making a parallel contribution to the observed changes in microvascular barrier properties, particularly in vessels with continuous endothelium.
Ang1 has heparin-binding/extracellular matrix-binding properties, 40 and could modify the barrier properties endowed by the endothelial glycocalyx by altering glycocalyx biochemical structure. The receptors and downstream signalling pathways responsible for this effect represent an opportunity for further investigation. The time-course for the Ang1-induced changes in glycocalyx effects (permeability coefficients and glycocalyx thickness both changed within 30 min of exposure) indicate that synthesis of de novo glycocalyx constituents is unlikely to be responsible. Ang1 is capable of altering the cell surface expression of other molecules over a similar time-course (e.g. Tie2 40 ), and microtubule-dependent trafficking of heparan sulphate has been observed in polarised renal epithelial cells. 41 Translocation of glycocalyx constituents from stores within endothelial cells to the plasmalemma may therefore explain the observed phenomena. We support this contention by demonstrating that inhibiting the translocation of Golgi vesicles, which transport glycosaminoglycans (e.g. hyaluronan 22 ) to the cell surface, inhibited the effect of Ang1 on L P . Brefeldin-A disrupts translocation of cellular material in minutes 39 and this is in keeping with our observations of altered L P and glycocalyx depth over this period.
The observations that Ang1 increased glycocalyx depth and decreased L P accords with theoretical predictions that the hydraulic resistance of the glycocalyx is determined by its depth. However, a change in the molecular constitution or arrangement of the glycocalyx is necessary to explain any change in molecular sieving, 33 and Ang1 may therefore translocate different glycocalyx constituents, or glycocalyx constituents in different proportions, from those observed under baseline conditions. Different effects of Ang1 on different aspects of endothelial cell biology may occur in parallel (e.g. restoration of continuity between glycocalyx and plasmalemma at the endothelial cell surface, and changes in interendothelial cleft molecules), and may contribute to the multiplicity of changes in permeability coefficients observed in different types of microvessels in these studies.
In summary, we show for the first time that Ang1 alters microvascular permeability coefficients of intact microvessels under baseline conditions in vivo. This provides a physiological mechanism for previous reports that Ang1 alters transmural flux of solutes and tracers. We present anatomical, biochemical, and physiological evidence for Ang1-induced modification of a structure that is common to both continuous and fenestrated endothelia-the endothelial glycocalyx-and suggest that these modifications contribute to the Ang1-induced changes in microvascular barrier function.
